Unknown

Dataset Information

0

Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs.


ABSTRACT: Current recommendations advocate treatment with disease-modifying anti-rheumatic drugs (DMARDs) in all patients with active rheumatoid arthritis (RA). We analyzed short-term disease outcome in patients according to the consistency of DMARD use in a clinical rheumatology cohort.Patients in an RA registry (n = 617) were studied for DMARD use at semi-annual study time points during the first 18 months of follow-up and were divided into 4 groups according to the number of study time points with any DMARD use [0-1 study time points (n = 31), 2 study time points (n = 24), 3 study time points (n = 77), and 4 study time points (n = 485)]. The primary outcome analyses were performed at 24 months and included Disease Activity Score 28 (DAS28-CRP), modified Health Assessment Questionnaire (MHAQ) change, Short Form Health Survey-12 physical and mental summary scores (SF-12 PCS, SF-12 MCS), EuroQol 5-Dimensional health index (EQ-5D), and radiographic progression. Unadjusted, adjusted, and analyses stratified for seropositivity and disease activity were performed. A secondary analysis investigated 36-month outcomes.No significant 24-month outcome differences could be found between the DMARD use categories. For seropositive patients, there was evidence of a linear trend for SF-12 PCS (p = 0.02) and EQ-5D (p = 0.01) with worse outcomes for inconsistent DMARD users. At 36 months, there was a linear trend for higher DAS28-CRP scores for inconsistent users (p < 0.01).Overall, we found poor correlation between inconsistent DMARD use and short-term disease outcome. However, outcome in the longer term could be negatively influenced by inconsistent DMARD use, as well as short-term outcome in seropositive patients.

SUBMITTER: Mjaavatten MD 

PROVIDER: S-EPMC4843117 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs.

Mjaavatten Maria D MD   Radner Helga H   Yoshida Kazuki K   Shadick Nancy A NA   Frits Michelle L ML   Iannaccone Christine K CK   Kvien Tore K TK   Weinblatt Michael E ME   Solomon Daniel H DH  

Seminars in arthritis and rheumatism 20140827 4


<h4>Objective</h4>Current recommendations advocate treatment with disease-modifying anti-rheumatic drugs (DMARDs) in all patients with active rheumatoid arthritis (RA). We analyzed short-term disease outcome in patients according to the consistency of DMARD use in a clinical rheumatology cohort.<h4>Methods</h4>Patients in an RA registry (n = 617) were studied for DMARD use at semi-annual study time points during the first 18 months of follow-up and were divided into 4 groups according to the num  ...[more]

Similar Datasets

| S-EPMC8065312 | biostudies-literature
| S-EPMC7733714 | biostudies-literature
| S-EPMC8078346 | biostudies-literature
| S-EPMC4843119 | biostudies-literature
| S-EPMC7596471 | biostudies-literature
| S-EPMC6827260 | biostudies-literature
| S-EPMC6607518 | biostudies-literature
| S-EPMC4883258 | biostudies-other
| S-EPMC6199417 | biostudies-literature
| S-EPMC4219583 | biostudies-literature